Perspectives on drugs: Hepatitis C Treatment for Injecting Drug Users
![Hepatitis-C-treatment-for-injecting-drug-users](/sites/default/files/styles/publications_wide_945/public/Hepatitis%2520C%2520treatment%2520for%2520injecting%2520drug%2520users.jpg?itok=G-vXnQUL)
Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today.In this analysis, the EMCDDA looks at some of the positive advances in treating the disease, including a new generation of medicines.
Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.
Year
2015